InvestorsHub Logo
Followers 826
Posts 119567
Boards Moderated 15
Alias Born 09/05/2002

Re: None

Thursday, 09/03/2015 4:19:13 PM

Thursday, September 03, 2015 4:19:13 PM

Post# of 179
FDA asks CHRS to increase size of immunogenicity study for Neulasta FoB:

http://finance.yahoo.com/news/coherus-provides-updates-clinical-studies-200100562.html

That CHRS is holding a CC (5pm ET today) to explain the change makes it seem like a bigger deal than it otherwise would have.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CHRS News